EUVIMEDEUVIMED entdecken
Crossref

Aberrant promoter methylation of CTHRC1 gene and its clinicopathological characteristics in head and neck cancer

A R Kumar, B Kannan, S Girija As, V P Jayaseelan, P Arumugam

International Journal of Oral and Maxillofacial Surgery · 2025

DOI: 10.1016/j.ijom.2025.01.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oral and Maxillofacial Surgery, 2025. Verfasst von A R Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University…. Hauptthemen laut MEDLINE: DNA Methylation, Extracellular Matrix Proteins, Head and Neck Neoplasms, Promoter Regions, Genetic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Saveetha Dental College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Head and neck squamous cell carcinoma (HNSCC) is genetically complex and difficult to treat. Detection in the early stage is challenging, leading to diagnosis at advanced stages with limited treatment options. This study examined the collagen triple helix repeat containing 1 gene (CTHRC1) as a potential biomarker and therapeutic target in HNSCC. Despite documented CTHRC1 upregulation in various cancers, the underlying causes remain unclear. The objective was to investigate potential epigenetic regulation of CTHRC1 expression through the analysis of promoter methylation. CTHRC1 DNA methylation, mRNA, and its protein expression were analysed using The Cancer Genome Atlas (TCGA) HNSCC cohort and oral squamous cell carcinoma (OSCC) patient samples. Functional analysis included scrutinizing the protein-protein interaction network and associations with DisGeNET (disease gene network). Various statistical methods were employed for analysis. HNSCC tumours exhibited significant hypomethylation of CTHRC1 DNA, correlating with advanced disease features. Elevated mRNA and protein expression of CTHRC1 further support its role in disease progression. High CTHRC1 gene expression was associated with a poorer prognosis. The protein interaction network implicated crucial pathways in cancer development and links to oral submucous fibrosis. Despite the limitations of this study, including the use of retrospective data and need for functional experiments, CTHRC1 shows potential as a prognostic predictor and target for therapeutic applications in HNSCC, paving the way for further research and improved patient management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationExtracellular Matrix ProteinsHead and Neck NeoplasmsPromoter Regions, GeneticCarcinoma, Squamous CellSquamous Cell Carcinoma of Head and NeckHumansMaleFemaleBiomarkers, TumorGene Expression Regulation, NeoplasticMiddle AgedPrognosisRNA, MessengerEpigenesis, GeneticDisease Progression

Stichwörter der Autor:innen

BiomarkerDNA methylationGeneticsHead and neck squamous cell carcinomasPrognostic factors

Substanzen

Extracellular Matrix ProteinsCTHRC1 protein, humanBiomarkers, TumorRNA, Messenger

Autor:innen und Institutionen

  • Department of Microbiology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
  • Molecular Biology Laboratory, Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
  • Clinical Genetics Laboratory, Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India.
  • Molecular Biology Laboratory, Centre for Cellular and Molecular Research, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, India. Electr…

Förderung

  • Saveetha Dental College

Zitieren

APA

R Kumar, A., Kannan, B., Girija As, S., Jayaseelan, V. P., & Arumugam, P. (2025). Aberrant promoter methylation of CTHRC1 gene and its clinicopathological characteristics in head and neck cancer. International Journal of Oral and Maxillofacial Surgery. https://doi.org/10.1016/j.ijom.2025.01.005

Vancouver

R Kumar A, Kannan B, Girija As S, Jayaseelan VP, Arumugam P. Aberrant promoter methylation of CTHRC1 gene and its clinicopathological characteristics in head and neck cancer. International Journal of Oral and Maxillofacial Surgery. 2025. doi:10.1016/j.ijom.2025.01.005

BibTeX
@article{RKumar2025,
  author = {R Kumar, A and Kannan, B and Girija As, S and Jayaseelan, V P and Arumugam, P},
  title = {Aberrant promoter methylation of CTHRC1 gene and its clinicopathological characteristics in head and neck cancer},
  journal = {International Journal of Oral and Maxillofacial Surgery},
  year = {2025},
  doi = {10.1016/j.ijom.2025.01.005}
}
Kostenlos starten →